New lentiviral vector for optimization of advanced therapies and control of cellular processes

Technology collaboration – TOES20150428001 OFFER

A Spanish public research organization has developed a product based on the application of a lentiviral vector with self-limited regulated expression. It can be used in cellular processes and advanced therapies, especially those in which cell differentiation is required. They are looking for licensees for patent application working in human and animal pharmaceutical fields interested in a licensing or research collaboration agreement for further development of the technology.

Powered by WPeMatico